新西兰成人百日咳流行病学:基于国家行政数据集的成人百日咳发病率及合并症关联回顾性分析
该回顾性观察性队列研究利用新西兰国家行政数据集链接形成2008–2019年成人健康服务使用者队列,计算百日咳年发病率并分析其与慢性合并症的关联。结果显示2012年发病率最高(84.77/10万人年),既往有合并症诊断者发生百日咳通知或诊断的风险增加16%(Adjusted-HR 1.162),作者建议对合并症患者推荐接种百日咳疫苗。
要点
- 2008–2019年成人队列中报告11,139例百日咳,2012年发病率最高达84.77/10万人年。
- 既往合并症诊断者发生百日咳通知或诊断的风险增加16%(Adjusted-HR 1.162)。
- 作者建议对合并症患者推荐接种百日咳疫苗以降低感染风险和疾病严重程度。
核心结论
- 研究发现在成人健康服务使用者队列中百日咳负担显著,近期有合并症诊断者百日咳风险更高。
- 作者建议对合并症患者推荐接种百日咳疫苗以降低感染风险和疾病严重程度。
- 作者指出全科医生需具备检测百日咳的能力,因其为法定报告疾病,对个人、家庭和更广泛人群均有影响。
- 作者认为高质量疾病监测对政策决策至关重要。
研究设计与样本
- 回顾性观察性队列研究,利用唯一国家健康索引标识符链接行政健康数据形成健康服务使用者队列。
- 队列2008年有2,907,258名参与者,至2019年增长至3,513,327名。
- 主要分析使用百日咳住院和通知数据计算年发病率;次要分析采用Cox比例风险生存分析探索成人百日咳与慢性合并症的关联。
主要发现
- 队列共报告11,139例百日咳病例。
- 2012年年发病率最高,为84.77/10万人年,显著影响女性、30–49岁人群以及欧洲裔或毛利裔。
- 调整社会人口学变量后,既往百日咳通知未显著增加合并症诊断风险(Adjusted-HR 0.972)。
- 既往有合并症诊断者发生百日咳通知或诊断的风险增加16%(Adjusted-HR 1.162)。
临床怎么用
- 作者建议对合并症患者推荐接种百日咳疫苗以降低感染风险和疾病严重程度。
- 作者指出全科医生需具备检测百日咳的能力,因其为法定报告疾病。
- 作者认为高质量疾病监测对政策决策至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In New Zealand, approximately half reported pertussis cases are adult. Studies indicate underestimated pertussis burden in this population and probable reservoir for childhood pertussis. Pertussis is linked to chronic obstructive pulmonary disease (COPD) development and increased risk with pre-existing COPD. While acellular pertussis vaccines are available for adults, data on pertussis disease burden in adults and association with COPD remain limited. AIM: To estimate pertussis incidence in New Zealand adult health service user (HSU) population aged ≥ 18 between 2008-2019 and inform adult pertussis vaccination strategies by assessing disease burden and risk factors in different adult populations. METHODS: Retrospective observational cohort study using an HSU cohort, formed by linking administrative health data using unique National Health Index identifier. For primary analysis, annual incidence rates were calculated using pertussis hospitalisations and notifications. In secondary analysis, Cox proportional hazards survival analyses explored association between pertussis in adults and chronic comorbidities. RESULTS: The cohort had 2,907,258 participants in 2008 and grew to 3,513,327 by 2019, with 11,139 pertussis cases reported. Highest annual incidence rate of 84.77 per 100,000 PYRS in 2012, notably affecting females, those aged 30-49 years, and European or Māori ethnicity. Adjusting for sociodemographic variables found no significant risk of prior pertussis notification leading to comorbidity diagnosis (Adjusted-HR: 0.972). However, individuals with prior comorbidity diagnosis had 16 % greater risk of receiving pertussis notification or diagnosis (Adjusted-HR: 1.162). CONCLUSIONS: Study found significant pertussis burden among the HSU adult cohort and highlighted higher risk of pertussis for those with recent comorbidity diagnoses. Vaccination for pertussis should be recommended for individuals with comorbidities to reduce infection risk and disease severity. GPs must have capability to test for pertussis, given it is notifiable disease with implications for individuals, their families, and broader population. High-quality disease surveillance is crucial for informing policy decisions.
引用
- Howard Ludlam A, Paynter J, Goodyear-Smith F, et al. Pertussis epidemiology in adults: Retrospective analysis of pertussis incidence and association with comorbidities among adult populations in Aotearoa New Zealand, using national administrative datasets. Vaccine. 2024. PMID: 38910093. doi:10.1016/j.vaccine.2024.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。